Breaking News Instant updates and real-time market news.

WBA

Walgreens Boots Alliance

$79.82

-2.11 (-2.58%)

, HUM

Humana

$307.50

-2.87 (-0.92%)

08:00
11/21/18
11/21
08:00
11/21/18
08:00

Jefferies not sure how Humana would benefit from Walgreens stake

The stake talks between Walgreens Boots Alliance (WBA) and Humana (HUM), as reported last night by the Wall Street Journal, follows in the pattern of the Aetna (AET)/CVS Health (CVS) deal, but it is not fully clear how Humana would benefit from an investment in Walgreens, Jefferies analyst Brian Tanquilut tells investors in a research note. For Walgreens, a partnership approach matches the company's strategy and would help address questions about the long-term viability of the retail pharmacy model, adds the analyst. He believes partnering with Humana helps Walgreens drive market share. Further, a deal could also help strengthen Humana's brand and improve its ability to market directly to prospective insurance lives, especially as healthcare increasingly becomes consumer-focused, Tanquilut says.

WBA

Walgreens Boots Alliance

$79.82

-2.11 (-2.58%)

HUM

Humana

$307.50

-2.87 (-0.92%)

AET

Aetna

$204.15

-3.535 (-1.70%)

CVS

CVS Health

$75.52

-3.02 (-3.85%)

  • 27

    Nov

  • 27

    Nov

  • 02

    Dec

WBA Walgreens Boots Alliance
$79.82

-2.11 (-2.58%)

11/19/18
JEFF
11/19/18
NO CHANGE
JEFF
Jefferies uncovers signs of Amazon expanding prescription drug presence
Jefferies analyst Brian Tanquilut says his proprietary checks of Amazon.com's (AMZN) moves in the pharmacy space indicate that the online retailer has finally made moves to expand PillPack. However, the initial expansion phase appears focused on offering pharmacy services to Amazon employees in Washington. In his most recent webscrape, Tanquilut came across a new prescription license in WA, two pending Rx licenses in New Mexico and Indiana, and pharmacy technician and packaging/shipping job postings all linked to PillPack's Phoenix facility. These new developments signal the beginning of Amazon's prescription expansion via PillPack, Tanquilut tells investors in a research note. If Amazon were to rollout a more extensive PillPack offering to its own employee base, Rite Aid (RAD) could be most exposed to potential script transfers with Walgreens Boots Alliance (WBA) the least exposed among the public drugstores, says the analyst. He still believes that the impact of Amazon's pharmacy entry will take a while to materialize for drug stores CVS Health (CVS) and Walgreens.
10/12/18
RHCO
10/12/18
NO CHANGE
Target $75
RHCO
Hold
Walgreens Boots Alliance price target raised to $75 from $66 at SunTrust
SunTrust analyst David MacDonald raised his price target on Walgreens Boots Alliance (WBA) to $75 after its Q4 earnings beat and FY19 guidance yesterday. The analyst says the results were marked by "solid U.S. pharmacy performance" in spite of the ongoing reimbursement and generic headwinds. MacDonald also keeps his Hold rating, adding that while the company's cash flow remains "robust" and the integration of Rite Aid (RAD) is still on track, he is concerned about the challenging environment and ongoing degradation in gross margins.
10/12/18
LOOP
10/12/18
NO CHANGE
Target $82
LOOP
Buy
Walgreens Boots Alliance price target raised to $82 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on Walgreens Boots Alliance to $82 from $80 after its Q4 earnings beat and "constructive" outlook for FY19. The analyst notes however that earnings quality was "mixed", with upside coming from lower-than-modeled share count and tax rate along with curtailment of some of the employee benefits. Wolf also keeps his Buy, noting that the management's FY19 guidance was set "conservatively" with some optimism of normalizing gross margins.
10/08/18
RBCM
10/08/18
NO CHANGE
Target $82
RBCM
Outperform
Walgreens Boots Alliance price target raised to $82 from $68 at RBC Capital
RBC Capital analyst George Hill raised his price target on Walgreens Boots Alliance to $82 and kept his Outperform rating ahead of its Q4 results and FY19 guidance this week, saying its outlook should come in better than expected thanks to the company's share repurchases. The analyst warns that he still has some concerns about Walgreens Boots' pricing in the U.S. after its commentary that followed the Q3 results but still expects the Medicare Part D preferred pharmacy network business to recover next year from the headwinds experienced in 2018. Hill also expects investors to focus on the company's organic script growth expectation as well as its "partnership strategy, pharmacy reimbursement trends, and drug pricing or regulatory changes".
HUM Humana
$307.50

-2.87 (-0.92%)

10/11/18
SPHN
10/11/18
NO CHANGE
SPHN
Stephens says home health final rule looking like draft would weigh on providers
Stephens analyst Dana Hambly said he expects the final rule for home health reimbursement to be released by CMS in the first week of November. He is concerned that if the final rule looks similar to the draft rule, particularly regarding behavioral assumptions, it would weigh on home health stocks. For-profit, urban providers with higher percentages of therapy visits are estimated to take the largest cuts under a Patient Driven Groupings Model for reimbursement, said Hambly, who sees the impact being largest for Brookdale Senior Living (BKD) and Humana's (HUM) Kindred at Home. Others that may be impacted include Amedisys (AMED), Encompass Health (EHC), Ensign Group (ENSG) and LHC Group (LHCG).
11/08/18
OPCO
11/08/18
NO CHANGE
Target $373
OPCO
Outperform
Humana price target raised to $373 from $350 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Humana to $373 from $350 after the company produced another quarter of "strong" results and provided a bullish outlook into 2019. Given the company is most leveraged to the high-growth Medicare Advantage business, the analyst remains bullish on the stock for long-term investors. He reiterates an Outperform rating on the shares.
11/08/18
FBCO
11/08/18
NO CHANGE
Target $390
FBCO
Outperform
Humana price target raised to $390 from $370 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Humana to $390 from $370 following quarterly results. The analyst reiterates an Outperform rating on the shares.
11/08/18
JEFF
11/08/18
NO CHANGE
Target $410
JEFF
Buy
Humana price target raised to $410 from $388 at Jefferies
Jefferies analyst David Windley raised his price target for Humana to $410 saying he's encouraged by the company's "solid" Q3 results. The analyst keeps a Buy rating on the shares.
AET Aetna
$204.15

-3.535 (-1.70%)

11/13/18
ARGS
11/13/18
NO CHANGE
Target $100
ARGS
Buy
CVS Health price target raised to $100 from $88 at Argus
Argus analyst Chris Graja raised his price target on CVS Health (CVS) to $100 and kept his Buy rating after its Q3 earnings beat, saying he remains "bullish on the management's ability to find innovative and profitable ways to reduce healthcare costs and deliver better care". The analyst also notes that he sees "significant upside for the shares if the company can close acquisition of Aetna (AET) and deliver on its financial targets". To that end, Graja cites the management's confidence expressed on the earnings call that the transaction can be closed prior to Thanksgiving and yield more than the initially estimated $750M in 2-year synergy benefits.
11/08/18
LEER
11/08/18
NO CHANGE
Target $95
LEER
Outperform
CVS Health price target raised to $95 from $85 at Leerink
Leerink analyst David Larsen raised his price target for CVS Health (CVS) to $95 from $85 following quarterly results. The analyst is encouraged that the deal with Aetna (AET) appears to be ready to close in the near-term, which he believes will be a positive catalyst for the stock. Larsen also likes how the PBM selling season seems to be progressing well, better than he had expected, and also likes how CVS seems to be re-focusing on the Retail "Streamline" efforts, which will hopefully result in net savings in 2019. The analyst reiterates an Outperform rating on CVS shares.
11/07/18
MSCO
11/07/18
NO CHANGE
Target $100
MSCO
Overweight
CVS Health price target raised to $100 from $80 at Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser said he believes the combination of CVS (CVS) and Aetna (AET) has the potential to transform the delivery of care as he introduced pro forma estimates for the combined company. He noted the wide range of consensus estimates, with EPS ranges from $6.63-$8.21 for 2019 and $7.45-$9.05 for 2020, while telling investors that his own pro-forma EPS forecasts are for $7.57 in 2019 and $8.30 in 2020. In setting up a valuation framework for the combined company, Goldwasser raised his price target on CVS shares to $100 from $80 and keeps an Overweight rating on the stock.
10/31/18
PIPR
10/31/18
DOWNGRADE
Target $206
PIPR
Neutral
Piper downgrades Aetna to Neutral on confidence of CVS deal closing
Piper Jaffray analyst Sarah James last night downgraded Aetna (AET) to Neutral from Overweight and lowered her price target for the shares to $206 from $212. The analyst is favorable on the fundamentals of Aetna's business and is confident the CVS Health (CVS) takeover will close given the recent Department of Justice approval. She believes Aetna shares will be range bound near the $206 per share takeout price.
CVS CVS Health
$75.52

-3.02 (-3.85%)

11/09/18
LOOP
11/09/18
NO CHANGE
Target $80
LOOP
Hold
CVS Health price target raised to $80 from $70 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on CVS Health shares to $80 from $70, citing improved sales results from CVS's core business units in Q3 and the company's maintenance of 2018 guidance. He also notes that the sector rotation into more defensive stocks has boosted the valuations of most of the other large-cap names in the group. However, Wolf keeps a Hold rating on CVS shares, noting that while its Q3 adjusted EPS of $1.73 topped consensus, it missed his own $1.78 forecast.

TODAY'S FREE FLY STORIES

BNFT

Benefitfocus

$49.88

-1.99 (-3.84%)

20:44
12/18/18
12/18
20:44
12/18/18
20:44
Hot Stocks
Benefitfocus sees FY19 revenue growth in 'mid-to-high teens' »

Sees FY19 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

AGCO

Agco

$56.59

2.7 (5.01%)

20:36
12/18/18
12/18
20:36
12/18/18
20:36
Earnings
Agco guides initial FY19 EPS ~$4.60, consensus $4.59 »

Sees FY19 revenue around…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NVS

Novartis

$85.40

-0.4 (-0.47%)

20:28
12/18/18
12/18
20:28
12/18/18
20:28
Hot Stocks
Novartis announces licensing of pradigastat to Anji Pharmaceuticals »

Anji Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

SQ

Square

$59.91

1.28 (2.18%)

20:25
12/18/18
12/18
20:25
12/18/18
20:25
Recommendations
Square analyst commentary at Tigress Financial »

Square offers continued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PAYX

Paychex

$64.32

-0.63 (-0.97%)

, GIS

General Mills

$36.70

-0.03 (-0.08%)

20:25
12/18/18
12/18
20:25
12/18/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PAYX

Paychex

$64.32

-0.63 (-0.97%)

GIS

General Mills

$36.70

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Dec

FSNUY

Fresenius SE

$0.00

(0.00%)

20:21
12/18/18
12/18
20:21
12/18/18
20:21
Upgrade
Fresenius SE rating change at Goldman Sachs »

Fresenius SE upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNFT

Benefitfocus

$49.88

-1.99 (-3.84%)

20:19
12/18/18
12/18
20:19
12/18/18
20:19
Recommendations
Benefitfocus analyst commentary at Jefferies »

Benefitfocus analyst day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FN

Fabrinet

$51.13

2.17 (4.43%)

20:06
12/18/18
12/18
20:06
12/18/18
20:06
Recommendations
Fabrinet analyst commentary at Piper Jaffray »

Fabrinet among the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$33.96

0.17 (0.50%)

19:38
12/18/18
12/18
19:38
12/18/18
19:38
Upgrade
Sealed Air rating change at BMO Capital »

Sealed Air upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$124.29

-0.2 (-0.16%)

19:31
12/18/18
12/18
19:31
12/18/18
19:31
Hot Stocks
Vice President of Caterpillar Excavation unit to step down »

Caterpillar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$71.99

-2.01 (-2.72%)

19:10
12/18/18
12/18
19:10
12/18/18
19:10
Periodicals
Exxon tells EPA it opposes weakening Obama-era emissions rules, Reuters says »

Exxon Mobil issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

CBS

CBS

$46.21

-0.6 (-1.28%)

, DIS

Disney

$109.43

-1.2 (-1.08%)

19:07
12/18/18
12/18
19:07
12/18/18
19:07
Periodicals
CBS poised to ramp up CEO search after denying Moonves severance, Bloomberg says »

CBS's (CBS) board is…

CBS

CBS

$46.21

-0.6 (-1.28%)

DIS

Disney

$109.43

-1.2 (-1.08%)

FOX

21st Century Fox

$48.49

-0.29 (-0.59%)

FOXA

21st Century Fox

$48.78

-0.22 (-0.45%)

TRCO

Tribune Media

$45.25

-0.08 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

  • 05

    Feb

JBL

Jabil

$22.21

0.65 (3.01%)

, SCS

Steelcase

$14.19

0.02 (0.14%)

19:02
12/18/18
12/18
19:02
12/18/18
19:02
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Jabil…

JBL

Jabil

$22.21

0.65 (3.01%)

SCS

Steelcase

$14.19

0.02 (0.14%)

ADMS

Adamas Pharmaceuticals

$8.11

-0.67 (-7.63%)

ANGI

Angi Homeservices

$15.64

-0.01 (-0.06%)

MU

Micron

$34.12

0.23 (0.68%)

LRCX

Lam Research

$138.01

2.39 (1.76%)

AMAT

Applied Materials

$33.27

0.62 (1.90%)

FDX

FedEx

$185.01

2.81 (1.54%)

UPS

UPS

$97.25

0.33 (0.34%)

SURF

Surface Oncology

$7.35

-0.44 (-5.65%)

GSAT

Globalstar

$0.36

0.0082 (2.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 08

    Jan

  • 19

    Dec

CBS

CBS

$46.21

-0.6 (-1.28%)

18:45
12/18/18
12/18
18:45
12/18/18
18:45
Periodicals
CBS poised to ramp up CEO search after denying Moonves severance, Bloomberg says »

CBS's board is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

AMTB

Mercantil Bank

$12.00

-0.3 (-2.44%)

18:41
12/18/18
12/18
18:41
12/18/18
18:41
Syndicate
Mercantil Bank 6.3M share IPO priced at $13.00 per share »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

QDEL

Quidel

$50.00

0.9 (1.83%)

18:39
12/18/18
12/18
18:39
12/18/18
18:39
Hot Stocks
Quidel receives CE Mark for Sofia 2 Lyme+ FIA for use with Sofia 2 instrument »

Quidel Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAOI

Applied Optoelectronics

$15.40

-1.73 (-10.10%)

, ACIA

Acacia Communications

$39.32

-0.53 (-1.33%)

18:34
12/18/18
12/18
18:34
12/18/18
18:34
Recommendations
Applied Optoelectronics, Acacia Communications, Cisco, Fabrinet, Finisar analyst commentary at Piper Jaffray »

Cisco's Luxtera deal…

AAOI

Applied Optoelectronics

$15.40

-1.73 (-10.10%)

ACIA

Acacia Communications

$39.32

-0.53 (-1.33%)

CSCO

Cisco

$44.05

-0.16 (-0.36%)

FN

Fabrinet

$51.13

2.17 (4.43%)

FNSR

Finisar

$21.57

0.005 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

WGO

Winnebago

$19.96

-0.73 (-3.53%)

18:20
12/18/18
12/18
18:20
12/18/18
18:20
Hot Stocks
Winnebago to withdraw its Chicago Stock Exchange listing »

Winnebago Industrie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

CVS

CVS Health

$69.55

-1.12 (-1.58%)

, AET

Aetna

$0.00

(0.00%)

18:07
12/18/18
12/18
18:07
12/18/18
18:07
Periodicals
Judge weighs naming monitor to oversee CVS during court process, Reuters says »

Judge Richard Leon of the…

CVS

CVS Health

$69.55

-1.12 (-1.58%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

FDX

FedEx

$185.01

2.81 (1.54%)

, AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

18:05
12/18/18
12/18
18:05
12/18/18
18:05
Hot Stocks
FedEx sees no impact from Amazon's air freight ops »

FedEx (FDX) says it is…

FDX

FedEx

$185.01

2.81 (1.54%)

AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 04

    Jan

  • 07

    Jan

VZ

Verizon

$55.67

-0.29 (-0.52%)

18:04
12/18/18
12/18
18:04
12/18/18
18:04
Hot Stocks
Verizon Media Group will replace the Oath brand »

Oath COO Guru Gowrappan …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

CE

Celanese

$85.39

0.98 (1.16%)

18:02
12/18/18
12/18
18:02
12/18/18
18:02
Hot Stocks
Celanese raises GUR and GHR grades engineered materials prices by 10% »

Celanese announced price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$185.01

2.81 (1.54%)

17:55
12/18/18
12/18
17:55
12/18/18
17:55
Hot Stocks
Breaking Hot Stocks news story on FedEx »

FedEx says profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FDX

FedEx

$185.01

2.81 (1.54%)

17:52
12/18/18
12/18
17:52
12/18/18
17:52
Hot Stocks
FedEx sees voluntary buyout saving company $225M-$275M in FY20 »

Sees 18-24 month payback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VVV

Valvoline

$19.00

0.21 (1.12%)

17:51
12/18/18
12/18
17:51
12/18/18
17:51
Hot Stocks
Valvoline to open 17 acquired Quick-Lube centers in California »

Valvoline Inc. - a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.